These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Local treatment of generalised peritonitis in rats; effects on bacteria, endotoxin and mortality. Rosman C; Westerveld GJ; Kooi K; Bleichrodt RP Eur J Surg; 1999 Nov; 165(11):1072-9. PubMed ID: 10595613 [TBL] [Abstract][Full Text] [Related]
5. Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin. Karadeniz C; Oğuz A; Canter B; Serdaroğlu A Pediatr Hematol Oncol; 2000; 17(7):585-90. PubMed ID: 11033734 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic necrosis: to debride or not to debride-that is the question. Warshaw AL Ann Surg; 2000 Nov; 232(5):627-9. PubMed ID: 11066132 [No Abstract] [Full Text] [Related]
7. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Büchler MW; Gloor B; Müller CA; Friess H; Seiler CA; Uhl W Ann Surg; 2000 Nov; 232(5):619-26. PubMed ID: 11066131 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and clinical evaluation of serious infections in premature and newborn infants under therapy with imipenem/cilastatin. Böswald M; Döbig C; Kändler C; Krüger C; Scharf J; Soergel F; Zink S; Guggenbichler JP Infection; 1999; 27(4-5):299-304. PubMed ID: 10885853 [TBL] [Abstract][Full Text] [Related]
9. Treatment of intra-abdominal infections using imipenem/cilastatin. Leaper D; Thomas W; Kennedy R; Leow C; Avery D Chemioterapia; 1987 Jun; 6(2 Suppl):467-8. PubMed ID: 3334603 [No Abstract] [Full Text] [Related]
10. Neurological complication during imipenem/cilastatin therapy in uraemic patients. Campise M Nephrol Dial Transplant; 1998 Jul; 13(7):1895-6. PubMed ID: 9681765 [No Abstract] [Full Text] [Related]
11. [Use of antibiotic thienam in critical care patients]. Mariutin PV; Uchvatkin VG Anesteziol Reanimatol; 1995; (4):67-8. PubMed ID: 7486202 [No Abstract] [Full Text] [Related]
12. Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections. Zanetti G; Harbarth SJ; Trampuz A; Ganeo M; Mosimann F; Chautemps R; Morel P; Lew D; Zimmerli W; Lange J; Glauser M Int J Antimicrob Agents; 1999 Feb; 11(2):107-13. PubMed ID: 10221413 [TBL] [Abstract][Full Text] [Related]
13. [News on antibiotic prophylaxis of necrosis infection in severe acute pancreatitis: the Italian viewpoint]. Rünzi M; Isenmann R Z Gastroenterol; 1999 Aug; 37(8):765-7. PubMed ID: 10494614 [No Abstract] [Full Text] [Related]
14. [Selective intraarterial application of Thienam and Vasoprostan in the treatment of purulent foot diseases in patients with diabetes mellitus]. Antsypovich EA; Molchanov VF; Kadyshev IuG; Brusnitsyna MA Klin Khir; 1998; (8):53. PubMed ID: 9866335 [No Abstract] [Full Text] [Related]
15. Peritonitis after gynecological and gastroscopic examinations in a peritoneal dialysis patient. Morimoto S; Kido E; Higashi M; Sumitani N; Takagishi H; Kakimoto S; Someya K; Morita T; Iwasaka T; Suzuki K; Yasui A Clin Nephrol; 2010 Dec; 74(6):491-2. PubMed ID: 21084055 [No Abstract] [Full Text] [Related]
16. [Thienam treatment in early postoperative period after pneumonectomy in patients with lung cancer]. Potanin VP; Taziev RM; Sigal EI; Krasin VV; Khalimov ID; Potanin AV; Sigal RI; Latypov AG Khirurgiia (Mosk); 2001; (10):47-8. PubMed ID: 11763820 [No Abstract] [Full Text] [Related]
17. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections. Hou F; Li J; Wu G; Zheng B; Chen Y; Gu J; Wang H; Huo L; Xue X; Jia C; Yin Y; Tian X; Ren S Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937 [TBL] [Abstract][Full Text] [Related]
18. [Primary peritonitis caused by Streptococcus pneumoniae]. Garnache F; Simon M; Goffinet P J Gynecol Obstet Biol Reprod (Paris); 1997; 26(6):617-22. PubMed ID: 9453979 [TBL] [Abstract][Full Text] [Related]
19. [Selective intra-arterial use of small doses of thienam and vasaprostanin the treatment of suppurative diseases of the foot in patients with diabetes mellitus]. Antsypovich EA; Molchanov VF; Kadyshev IuG; Brusnitsyna MA Vestn Khir Im I I Grek; 1998; 157(1):76-7. PubMed ID: 9611324 [TBL] [Abstract][Full Text] [Related]